Status:
WITHDRAWN
Correlation of Serum Gasdermin-D and NLRP-3 Inflammasome Levels With GVHD Biomarkers and Endothelial Damage Markers in Graft-Versus-Host Disease
Lead Sponsor:
Ugur Arzu Kulu
Conditions:
Acute Myeloid Leukemia, Adult
Graft Versus Host Disease
Eligibility:
All Genders
18+ years
Brief Summary
The investigators aimed to reveal the relationship between serum markers of pyroptosis, GVHD biomarkers and endothelial damage markers in patients who were planned for allogeneic stem cell transplanta...
Detailed Description
In the study, in patients who were planned to receive allogeneic stem cell transplantation for AML, pre-transplant period (before and after central catheter insertion) and post-transplant period (+1, ...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Patients with acute myeloid leukemia undergoing allogeneic bone marrow transplantation
- Patients followed up by the Department of Hematology, Ankara University Faculty of Medicine Hospitals
Exclusion
- Patients under 18 years of age
- Patients with non-AML transplant indication
- Patients not followed up by the Department of Hematology, Ankara University Faculty of Medicine Hospitals
Key Trial Info
Start Date :
November 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 15 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06200441
Start Date
November 15 2023
End Date
November 15 2024
Last Update
January 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara University, Department of Hematology
Ankara, Turkey (Türkiye), 06000